Abstract
AbstractThe widespread use of body weight control agents might be related to liver enzyme elevation, but this potential association has only been documented in a few case reports. This study aimed to investigate the associations between weight loss agents and elevated liver enzymes at the population-level. We conducted a cross-sectional study using Korea National Health and Nutrition Examination Survey (KNHANES) data from 2013 to 2019. This study included 36,259 participants over 20 years of age who completed the questionnaire and had no history of hepatitis, cancer, or renal failure. In these participants, we analyzed associations between weight loss agents and elevated liver enzymes by constructing multiple logistic regression models with adjustment for confounding factors and stratified by sex, age, and body mass index. The use of weight loss agents related to liver enzyme elevation in men (adjusted odds ratio (aOR): 1.36, 95% confidence interval (CI): 1.08–1.71) and participants aged less than 40 years (aOR: 1.44, 95% CI: 1.12–1.87). Using more types of weight loss agents was associated with liver enzyme elevation (aOR: 1.31, 95% CI: 1.03–1.67 for 1 weight loss agent, aOR: 1.93, 95% CI: 0.93–3.99 for ≥ 2 weight loss agents). Elevated liver enzymes were associated with the use of traditional medicines (aOR: 1.96, 95% CI: 1.14–3.34) and dietary supplements (aOR: 1.33, 95% CI: 1.02–1.72) in men. We observed an association between weight loss agents and liver enzyme elevation in men, particularly for traditional herbal medicines and dietary supplements. To confirm the observed associations, studies higher on the evidence hierarchy are needed.
Funder
Korea Health Technology R&D Project through the Korea Health Industry Development Institute
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Korea Disease Control and Prevention Agency. Korea Health Statistics 2020: Korea National Health and Nutrition Examinatin Survey (KNHANES VIII-2) (2020).
2. Saunders, K. H., Umashanker, D., Igel, L. I., Kumar, R. B. & Aronne, L. J. Obesity pharmacotherapy. Med. Clin. N. Am. 102, 135–148 (2018).
3. Cheon, C. & Jang, B. H. Trends for weight control strategies in Korean adults using the Korea National Health and Nutrition Examination Survey from 2007 to 2017. Explore (NY) 17, 320–326 (2021).
4. Crescioli, G. et al. Acute liver injury following Garcinia cambogia weight-loss supplementation: Case series and literature review. Intern. Emerg. Med. 13, 857–872 (2018).
5. Suk, K. T. et al. A prospective nationwide study of drug-induced liver injury in Korea. ACG 107, 1380–1387 (2012).